0001437749-20-013988.txt : 20200626
0001437749-20-013988.hdr.sgml : 20200626
20200626160532
ACCESSION NUMBER: 0001437749-20-013988
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200624
FILED AS OF DATE: 20200626
DATE AS OF CHANGE: 20200626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ANDREWS RONALD ASBURY
CENTRAL INDEX KEY: 0001299153
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36200
FILM NUMBER: 20994152
MAIL ADDRESS:
STREET 1: 5791 VAN ALLEN WAY
CITY: CARLSBAD
STATE: CA
ZIP: 92008
FORMER NAME:
FORMER CONFORMED NAME: Andrews Ronald Asbury
DATE OF NAME CHANGE: 20040730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oxford Immunotec Global PLC
CENTRAL INDEX KEY: 0001586049
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
BUSINESS PHONE: 44 01235 442780
MAIL ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
4
1
rdgdoc.xml
FORM 4
X0306
4
2020-06-24
0001586049
Oxford Immunotec Global PLC
OXFD
0001299153
ANDREWS RONALD ASBURY
C/O OXFORD IMMUNOTEC GLOBAL PLC
94C INNOVATION DRIVE
ABINGDON, OXFORDSHIRE
X0
OX14 4RZ
UNITED KINGDOM
1
Ordinary Shares
2020-06-24
4
A
0
4081
0
A
4081
D
Share Option (Right to Buy)
12.96
2020-06-24
4
A
0
9494
0
A
2030-06-24
Ordinary Shares
9494
9494
D
Options granted under Issuer's 2013 Share Incentive Plan.
This option will vest and become exercisable as to 100% of the underlying shares on the earlier of the first anniversary of the date of grant or the date of the first annual general meeting of the shareholders held after the date of grant.
/s/ Matthew T E McLaughlin, as Attorney-in-Fact for Ronald Asbury Andrews, Jr.
2020-06-26